18F-Fluorodeoxyglucose Positron Emission Tomography-Based Assessment of Local Failure Patterns in Non-Small-Cell Lung Cancer Treated With Definitive Radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 5, 2008, Pages 1397-1402

  Sura, Sonal ^a   Greco, Carlo ^a   Gelblum, Daphna ^a   Yorke, Ellen D ^a   Jackson, Andrew ^a   Rosenzweig, Kenneth E ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Definitive radiotherapy; FDG PET scan; Local failure; Non small cell lung cancer

Indexed keywords

ONCOLOGY; PATIENT MONITORING; RADIOTHERAPY; TUMORS;

DEFINITIVE RADIOTHERAPY; FDG-PET SCAN; LOCAL FAILURE;

POSITRON EMISSION TOMOGRAPHY;

CISPLATIN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG NON SMALL CELL CANCER; MALE; POSITRON EMISSION TOMOGRAPHY; PRESCRIPTION; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OBSERVER VARIATION; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT FAILURE; TUMOR BURDEN;

EID: 40949112714     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.08.052     Document Type: Article

References (37)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Willner J., Baier K., Caragiani E., et al. Dose, volume, and tumor control predictions in primary radiotherapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 52 (2002) 382-389
3. Rengan R., Rosenzweig K.E., and Venkatraman E. Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 60 (2004) 741-747
4. Nelson C., Starkschall G., and Chang J.Y. The potential for dose escalation in lung cancer as a result of systematically reducing margins used to generate planning target volume. Int J Radiat Oncol Biol Phys 65 (2006) 573-586
5. Rosenzweig K.E., Sim S.E., Mychalczak B., et al. Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 50 (2001) 681-685
6. Onimaru R., Shirato H., Shimizu S., et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 56 (2003) 126-135
7. Senan S., Chapet O., Lagerwaard F.J., et al. Defining target volumes for non-small cell lung carcinoma. Semin Radiat Oncol 14 (2004) 308-314
8. Giraud P., Grahek D., Montravers F., et al. CT and (18)F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers. Int J Radiat Oncol Biol Phys 49 (2001) 1249-1257
9. Mah K., Caldwell C.B., Ung Y.C., et al. The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: A prospective study. Int J Radiat Oncol Biol Phys 52 (2002) 339-350
10. Ashamalla H., Rafla S., Parikh K., et al. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1016-1023
11. Ciernik I.F., Dizendorf E., Baumert B.G., et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasibility study. Int J Radiat Oncol Biol Phys 57 (2003) 853-863
12. Fox J.L., Rengan R., O'Meara W., et al. Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer?. Int J Radiat Oncol Biol Phys 62 (2005) 70-75
13. Erdi Y.E., Mawlawi O., Larson S.M., et al. Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding. Cancer 80 (1997) 2505-2509
14. Stevens C.W., Munden R.F., Forster K.M., et al. Respiratory-driven lung tumor motion is independent of tumor size, tumor location and pulmonary function. Int J Radiat Oncol Biol Phys 51 (2001) 62-68
15. Wong J.W., Sharpe M.B., Jaffray B., et al. The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys 44 (1999) 911-919
16. 18Fluoro-2-deoxyglucose positron emission tomography staging in radical radiotherapy candidates with non-small cell lung cancer. Cancer 92 (2001) 886-895
17. 18fluoro-2-deoxyglucose positron emission tomographic imaging to radiotherapy planning in lung cancer. Lung Cancer 19 (1998) 167-177
18. Erdi Y.E., Rosenzweig K.E., Erdi A.K., et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol 62 (2002) 51-60
19. Bradley J., Thorstad W., Mutic S., et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 59 (2004) 78-86
20. Greco C., Rosenzweig K.E., Cascini G., et al. Current status of PET/CT for tumour volume definition in radiotherapy treatment-planning for non small cell lung cancer (NSCLC). Lung Cancer 57 (2007) 125-135
21. De Ruysscher D., Wanders S., Van H.E., et al. Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: A prospective clinical study. Int J Radiat Oncol Biol Phys 62 (2005) 988-994
22. Belderbos J.S., Heemsbergen W.D., De J.K., et al. Final results of a phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 126-134
23. Erasmus J.J., Gladish G.W., Broemeling L., et al. Interobserver and intraobserver variability in measurement of non-small-cell lung carcinoma lung lesions: Implications for assessment of tumor response. J Clin Oncol 21 (2003) 2575-2582
24. MacManus M.P., Hicks R.J., Mathews J.P., et al. Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small cell lung cancer. J Clin Oncol 21 (2003) 1285-1292
25. Mohan R., Barest G., Brewster L.J., et al. A comprehensive three-dimensional radiation treatment planning system. Int J Radiat Oncol Biol Phys 15 (1988) 481-495
26. Burman C., Chui C.S., Kutcher G., et al. Planning, delivery and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: A strategy for large-scale implementation for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 39 (1997) 863-873
27. Spirou S.V., and Chui C.S. A gradient inverse planning algorithm with dose-volume constraints. Med Phys 25 (1998) 321-333
28. Chui C.S., LoSasso T., Spirou S., et al. Dose calculation for photon beams with intensity modulation generated by dynamic jaw or multileaf collimations. Med Phys 21 (1994) 1237-1244
29. Hicks R.J., MacManus M.P., Matthews J.P., et al. Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: Inflammatory changes in normal tissue correlate with tumor response and do not confound therapeutic response evaluation. Int J Radiat Oncol Biol Phys 60 (2004) 412-418
30. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
31. Lardinois D., Weder W., Hany T.F., et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348 (2003) 2500-2507
32. Munley M.T., Marks L.B., Scarfone C., et al. Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: Challenges and prospects. Lung Cancer 23 (1999) 105-114
33. De Wever W., Meylaerts L., De Ceuninck L., et al. Additional value of integrated PET-CT in the detection and characterization of lung metastases: Correlation with CT alone and PET alone. Eur Radiol 17 (2007) 467-473
34. Senan S., De R.D., Giraud P., et al. Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer. Radiother Oncol 71 (2004) 139-146
35. Vanuytsel L.J., Vansteenkiste J.F., Stroobants S.G., et al. The impact of (18)F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol 55 (2000) 317-324
36. 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: A modeling study. Int J Radiat Oncol Biol Phys 61 (2005) 649-655
37. Liu H.H., Wang X., Dong L., et al. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1268-1279